Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 13.4 | pmol/sample |
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 18.5 | pmol/sample |
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 18.9 | pmol/sample |
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 19.6 | pmol/sample |
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 27.9 | pmol/sample |
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 22.1 | pmol/sample |
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 30.3 | pmol/sample |
| - | 1,2-DG(36:1) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 40.1 | pmol/sample |
| - | 1,2-DG(36:1) | C | 0.0 | BCD100322A01 | 11.5 | pmol/sample |
| - | 1,2-DG(36:1) | C | 0.5 | BCD100322A03 | 8.39 | pmol/sample |
| - | 1,2-DG(36:1) | C | 1.0 | BCD100322A07 | 9.96 | pmol/sample |
| - | 1,2-DG(36:1) | C | 2.0 | BCD100322A11 | 20.2 | pmol/sample |
| - | 1,2-DG(36:1) | C | 4.0 | BCD100322A15 | 15.7 | pmol/sample |
| - | 1,2-DG(36:1) | C | 8.0 | BCD100322A19 | 19.8 | pmol/sample |
| - | 1,2-DG(36:1) | C | 12.0 | BCD100322A23 | 16.6 | pmol/sample |
| - | 1,2-DG(36:1) | C | 24.0 | BCD100322A27 | 8.04 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 11.9 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 31.8 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 14.6 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 14.3 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 23.3 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 26.3 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 23.4 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol | 0.5 | BCD100322A04 | 8.81 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol | 1.0 | BCD100322A08 | 14.7 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol | 2.0 | BCD100322A12 | 9.57 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol | 4.0 | BCD100322A16 | 9.41 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol | 8.0 | BCD100322A20 | 13.9 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol | 12.0 | BCD100322A24 | 14.8 | pmol/sample |
| - | 1,2-DG(36:1) | 25OH-Chol | 24.0 | BCD100322A28 | 8.61 | pmol/sample |